Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Open Humans: A platform for participant-centered research and personal data exploration.

Greshake Tzovaras B, Angrist M, Arvai K, Dulaney M, Estrada-Galiñanes V, Gunderson B, Head T, Lewis D, Nov O, Shaer O, Tzovara A, Bobe J, Price Ball M.

Gigascience. 2019 Jun 1;8(6). pii: giz076. doi: 10.1093/gigascience/giz076.

2.

Early Diagnosis of Defibrillation Lead Dislodgement.

Zaman JAB, Chua K, Sovari AA, Gunderson B, Gang ES, Ploux S, Swerdlow CD.

JACC Clin Electrophysiol. 2018 Aug;4(8):1075-1088. doi: 10.1016/j.jacep.2018.03.015. Epub 2018 May 2.

3.

How active are young cardiac device patients? Objective assessment of activity in children with cardiac devices.

de la Uz CM, Burch AE, Gunderson B, Koehler J, Sears SF.

Pacing Clin Electrophysiol. 2017 Nov;40(11):1286-1290. doi: 10.1111/pace.13197. Epub 2017 Oct 10.

PMID:
28901013
4.

Strategic Resource Use for Learning: A Self-Administered Intervention That Guides Self-Reflection on Effective Resource Use Enhances Academic Performance.

Chen P, Chavez O, Ong DC, Gunderson B.

Psychol Sci. 2017 Jun;28(6):774-785. doi: 10.1177/0956797617696456. Epub 2017 Apr 27.

PMID:
28447894
5.

Patient Activity Decreases and Mortality Increases After the Onset of Persistent Atrial Fibrillation in Patients With Implantable Cardioverter-Defibrillators.

Chelu MG, Gunderson BD, Koehler J, Ziegler PD, Sears SF.

JACC Clin Electrophysiol. 2016 Aug;2(4):518-523. doi: 10.1016/j.jacep.2016.01.015. Epub 2016 Apr 6.

6.

Examination of the differential impacts of antitachycardia pacing vs. shock on patient activity in the EMPIRIC study.

Sears SF, Whited A, Koehler J, Gunderson B.

Europace. 2015 Mar;17(3):417-23. doi: 10.1093/europace/euu305. Epub 2015 Jan 18.

PMID:
25600766
7.

Using a telephone call to increase social presence in online classes.

Gunderson BJ, Theiss MA, Wood LK, Conti-O'Hare M.

Nurs Educ Perspect. 2014 Sep-Oct;35(5):338-9. No abstract available.

PMID:
25291933
8.

Performance of Lead Integrity Alert to assist in the clinical diagnosis of implantable cardioverter defibrillator lead failures: analysis of different implantable cardioverter defibrillator leads.

Ellenbogen KA, Gunderson BD, Stromberg KD, Swerdlow CD.

Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1169-77. doi: 10.1161/CIRCEP.113.000744. Epub 2013 Oct 7.

PMID:
24099976
9.

Health plan utilization and costs of specialty drugs within 4 chronic conditions.

Gleason PP, Alexander GC, Starner CI, Ritter ST, Van Houten HK, Gunderson BW, Shah ND.

J Manag Care Pharm. 2013 Sep;19(7):542-8.

10.

Diagnosis of high-voltage conductor fractures in Sprint Fidelis leads.

Koneru JN, Gunderson BD, Sachanandani H, Wohl BN, Kendall KT, Swerdlow CD, Ellenbogen KA.

Heart Rhythm. 2013 Jun;10(6):813-8. doi: 10.1016/j.hrthm.2013.02.027. Epub 2013 Feb 27.

PMID:
23454808
11.

Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?

Tungol A, Starner CI, Gunderson BW, Schafer JA, Qiu Y, Gleason PP.

J Manag Care Pharm. 2012 Nov-Dec;18(9):690-700.

12.

Prevention of inappropriate ICD shocks due to lead insulation failure by continuous monitoring and automatic alert.

Gelder RN, Gunderson BD.

Pacing Clin Electrophysiol. 2012 Jun;35(6):e150-3. doi: 10.1111/j.1540-8159.2011.03316.x. Epub 2012 Feb 6.

PMID:
22309317
13.

Preventing overdiagnosis of implantable cardioverter-defibrillator lead fractures using device diagnostics.

Swerdlow CD, Sachanandani H, Gunderson BD, Ousdigian KT, Hjelle M, Ellenbogen KA.

J Am Coll Cardiol. 2011 Jun 7;57(23):2330-9. doi: 10.1016/j.jacc.2010.12.042.

14.

Determining the local origin of hydroxyl radical generation during phacoemulsification.

Aust SD, Terry S, Hebdon T, Gunderson B, Terry M, Dimalanta R.

J Cataract Refract Surg. 2011 Jun;37(6):1154-9. doi: 10.1016/j.jcrs.2010.12.055.

PMID:
21596259
15.

Price increases and new drugs drive increased expenditures for multiple sclerosis.

Schafer JA, Gunderson BW, Gleason PP.

J Manag Care Pharm. 2010 Nov-Dec;16(9):713-7. No abstract available.

16.

Downloadable software algorithm reduces inappropriate shocks caused by implantable cardioverter-defibrillator lead fractures: a prospective study.

Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Sachanandani H, Ellenbogen KA.

Circulation. 2010 Oct 12;122(15):1449-55. doi: 10.1161/CIRCULATIONAHA.110.962407. Epub 2010 Sep 27.

PMID:
20876433
17.

Causes of ventricular oversensing in implantable cardioverter-defibrillators: implications for diagnosis of lead fracture.

Gunderson BD, Swerdlow CD, Wilcox JM, Hayman JE, Ousdigian KT, Ellenbogen KA.

Heart Rhythm. 2010 May;7(5):626-33. doi: 10.1016/j.hrthm.2010.01.013. Epub 2010 Jan 15.

PMID:
20184977
18.

Association of prescription abandonment with cost share for high-cost specialty pharmacy medications.

Gleason PP, Starner CI, Gunderson BW, Schafer JA, Sarran HS.

J Manag Care Pharm. 2009 Oct;15(8):648-58.

19.

Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads.

Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Stadler RW, Gillberg JM, Patel AS, Ellenbogen KA.

Circulation. 2008 Nov 18;118(21):2122-9. doi: 10.1161/CIRCULATIONAHA.108.796136. Epub 2008 Nov 3.

PMID:
18981299
20.
21.

Effect of programmed number of intervals to detect ventricular fibrillation on implantable cardioverter-defibrillator aborted and unnecessary shocks.

Gunderson BD, Abeyratne AI, Olson WH, Swerdlow CD.

Pacing Clin Electrophysiol. 2007 Feb;30(2):157-65.

PMID:
17338710
22.
23.

Development and testing of an algorithm to detect implantable cardioverter-defibrillator lead failure.

Gunderson BD, Gillberg JM, Wood MA, Vijayaraman P, Shepard RK, Ellenbogen KA.

Heart Rhythm. 2006 Feb;3(2):155-62.

PMID:
16443529
24.

Temporal patterns of ventricular tachyarrhythmia recurrences follow a Weibull distribution.

Wood MA, Gunderson B, Xia A, Zhou X, Padmanabhan V, Ellenbogen KA.

J Cardiovasc Electrophysiol. 2005 Feb;16(2):181-5.

PMID:
15720457
25.

Automatic identification of clinical lead dysfunctions.

Gunderson BD, Patel AS, Bounds CA, Ellenbogen KA.

Pacing Clin Electrophysiol. 2005 Jan;28 Suppl 1:S63-7.

PMID:
15683528
26.

Are incentive-based formularies inversely associated with drug utilization in managed care?

Gleason PP, Gunderson BW, Gericke KR.

Ann Pharmacother. 2005 Feb;39(2):339-45. Epub 2005 Jan 11. Review.

PMID:
15644478
27.

An algorithm to predict implantable cardioverter-defibrillator lead failure.

Gunderson BD, Patel AS, Bounds CA, Shepard RK, Wood MA, Ellenbogen KA.

J Am Coll Cardiol. 2004 Nov 2;44(9):1898-902.

28.

Pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against Bacteroides fragilis and Bacteroides thetaiotaomicron.

Ibrahim KH, Gunderson BW, Hermsen ED, Hovde LB, Rotschafer JC.

Antimicrob Agents Chemother. 2004 Nov;48(11):4195-9.

29.

Incidence of nonsustained and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator.

Zhou X, Gunderson BD, Olson WH; Gem DR ICD Clinical Worldwide Investigators.

J Cardiovasc Electrophysiol. 2004 Jan;15(1):14-20.

PMID:
15028067
30.

Mood stabilizers in hospitalized children with bipolar disorder: a retrospective review.

Davanzo P, Gunderson B, Belin T, Mintz J, Pataki C, Ott D, Emley-Akanno C, Montazeri N, Oppenheimer J, Strober M.

Psychiatry Clin Neurosci. 2003 Oct;57(5):504-10.

31.

An adaptive interval-based algorithm for withholding ICD therapy during sinus tachycardia.

Stadler RW, Gunderson BD, Gillberg JM.

Pacing Clin Electrophysiol. 2003 May;26(5):1189-201.

PMID:
12765446
32.

Mutation prevention concentration of ceftriaxone, meropenem, imipenem, and ertapenem against three strains of Streptococcus pneumoniae.

Hovde LB, Rotschafer SE, Ibrahim KH, Gunderson B, Hermsen ED, Rotschafer JC.

Diagn Microbiol Infect Dis. 2003 Apr;45(4):265-7.

PMID:
12729997
33.

Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model.

Gunderson BW, Ibrahim KH, Hovde LB, Fromm TL, Reed MD, Rotschafer JC.

Antimicrob Agents Chemother. 2003 Mar;47(3):905-9.

34.
35.

Microbiologic effectiveness of time- or concentration-based dosing strategies in Streptococcus pneumoniae.

Ibrahim KH, Hovde LB, Ross G, Gunderson B, Wright DH, Rotschafer JC.

Diagn Microbiol Infect Dis. 2002 Nov;44(3):265-71.

PMID:
12493174
36.

Psychiatric illness in a clinical sample of children with prenatal alcohol exposure.

O'Connor MJ, Shah B, Whaley S, Cronin P, Gunderson B, Graham J.

Am J Drug Alcohol Abuse. 2002 Nov;28(4):743-54.

PMID:
12492268
37.

Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of staphylococci in an in vitro model under aerobic and anaerobic conditions.

Wright DH, Gunderson BW, Hovde LB, Ross GH, Ibrahim KH, Rotschafer JC.

Antimicrob Agents Chemother. 2002 May;46(5):1561-3.

38.

Pacemaker troubleshooting: improved efficacy using a new diagnostic digital Holter recording system.

Moak JP, Gunderson B, Freedenberg V, Ramwell C.

Europace. 2002 Jan;4(1):55-9.

PMID:
11846318
39.

What do we really know about antibiotic pharmacodynamics?

Gunderson BW, Ross GH, Ibrahim KH, Rotschafer JC.

Pharmacotherapy. 2001 Nov;21(11 Pt 2):302S-318S. Review.

PMID:
11714222
40.

Comparison of the adaptive functioning of children prenatally exposed to alcohol to a nonexposed clinical sample.

Whaley SE, O'Connor And MJ, Gunderson B.

Alcohol Clin Exp Res. 2001 Jul;25(7):1018-24.

PMID:
11505027
41.

Intensive care unit antimicrobial resistance and the role of the pharmacist.

Ibrahim KH, Gunderson B, Rotschafer JC.

Crit Care Med. 2001 Apr;29(4 Suppl):N108-13. Review.

PMID:
11292885
42.

Pharmacokinetics of pilocarpine in subjects with varying degrees of renal function.

St Peter JV, Lambrecht LJ, Gunderson BW, Andersen SA, Gallagher SC, Swan SK.

J Clin Pharmacol. 2000 Dec;40(12 Pt 2):1470-5.

PMID:
11185668
43.

Retrospective analysis of cisapride-induced QT changes in end-stage renal disease patients.

Hentges MJ, Gunderson BW, Lewis MJ.

Nephrol Dial Transplant. 2000 Nov;15(11):1814-8.

PMID:
11071970
44.

Inappropriate therapy from atrial fibrillation and sinus tachycardia in automated implantable cardioverter defibrillators.

Nanthakumar K, Paquette M, Newman D, Deno DC, Malden L, Gunderson B, Gilkerson J, Greene M, Heng D, Dorian P.

Am Heart J. 2000 May;139(5):797-803.

PMID:
10783212
45.

Detection of atrial fibrillation and flutter by a dual-chamber implantable cardioverter-defibrillator. For the Worldwide Jewel AF Investigators.

Swerdlow CD, Schsls W, Dijkman B, Jung W, Sheth NV, Olson WH, Gunderson BD.

Circulation. 2000 Feb 29;101(8):878-85.

PMID:
10694527
46.

On patient compliance with medication doses.

Ambrose PG, Garvey MJ, Gunderson B, Quintiliani R.

Pediatr Ann. 1997 Nov;26(11):649-50. No abstract available.

PMID:
9397442
47.

One-stop shopping wave of future.

Shvetzoff S, Gunderson B.

Provider. 1997 Apr;23(4):33-5. No abstract available.

PMID:
10166332
48.

Implantable pacer-cardioverter-defibrillator induced episode types and programming strategies.

Olson WH, Gunderson BD, Bardy GH.

J Electrocardiol. 1992;25 Suppl:145. No abstract available.

PMID:
1297682
49.

The mythology of threshold variations as a function of electrode surface area.

Stokes KB, Bird T, Gunderson B.

Pacing Clin Electrophysiol. 1991 Nov;14(11 Pt 2):1748-51.

PMID:
1721168
50.

Ribavirin.

Fusco G, Gunderson B.

Conn Med. 1987 Feb;51(2):103-4. No abstract available.

PMID:
3549137

Supplemental Content

Loading ...
Support Center